Prof Rosie Watson
Honorary (Professorial Fellow)
Department of Medicine
111 Scholarly works
2 Projects
HIGHLIGHTS
2026
Journal article
Use of blood-based neurofilament light chain as an endpoint in clinical trials of neurodegenerative conditions: a scoping review
DOI: 10.1007/s00415-026-14007-52026
Journal article
Cost-Effectiveness of Donanemab for Early Alzheimer Disease in Australia
DOI: 10.5694/mja2.701862026
Journal article
The prodromal presentation of dementia with Lewy bodies: Application of the proposed research criteria
DOI: 10.1002/dad2.703182026
Journal article
A phase 2, randomized, multicenter, double-blind, placebo-controlled trial of S-adenosyl methionine in participants with mild cognitive impairment or dementia due to Alzheimer's disease
DOI: 10.1002/alz.713812026
Journal article
Strength together: Risk and protective factors for dementia and cognitive impairment in Aboriginal and Torres Strait Islander peoples
DOI: 10.1016/j.inpsyc.2026.1002062021
Research grants (other domestic)
Clinical Trial \201CCOmBinging Memantine and Cholinesterase Inhibitors in Lewy Body Dementia Treatment Trial (COBALT)\201D
2021
Research grants (ARC, NHMRC, MRFF)
Combining Memantine and Cholinesterase Inhibitors in Lewy Body Dementia Treatment Trial (Cobalt)
RECENT SCHOLARLY WORKS
2026
Journal article
The Neuropsychiatric Symptom Profile of Mild Dementia With Lewy Bodies
DOI: 10.1177/089198872614381252025
Journal article
Feasibility of a blood biomarker cohort study within a memory clinic service
DOI: 10.1002/alz70856_1005982025
Journal article
A Prototype Rapid Tool to Enhance Detection of Dementia for Aboriginal and Torres Strait Islander Peoples in Primary Care
DOI: 10.1002/gps.701262025
Journal article
The prevalence of apathy in Lewy body dementia: A systematic review and meta-analysis
DOI: 10.1002/alz.704252025
Journal article
Blood biomarker profiles in young-onset neurocognitive disorders: A cohort study
DOI: 10.1177/00048674241312805